Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1999
12/09/1999CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0961831A1 Human endokine alpha
12/08/1999EP0961829A1 Fusion proteins for intracellular and intercellular transport and their uses
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0702565B1 Helicobacter pylori catalase-based immunising composition
12/08/1999EP0674631B1 Substituted pyrazoles as crf antagonists
12/08/1999EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999EP0640101B1 Methods and reagents for diagnosis of autoantibodies
12/08/1999EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals
12/08/1999EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999CN1238010A Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/08/1999CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/08/1999CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/08/1999CN1237906A New use for 1,3-propanediol derivatives
12/07/1999US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998476 Reaction product of unsaturated fatty acid with glycine or aspartic acid
12/07/1999US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999US5998403 Salts of azelastine having improved solubility useful at providing a cytoprotective effect
12/07/1999US5998376 Substance P treatment for immunostimulation
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998169 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997873 Method of preparation of heat shock protein 70-peptide complexes
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997865 Agonist antibodies against the flk2/flt3 receptor and uses thereof
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2119773C Macrophage activating factor from animal vitamin d-binding protein
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA2074943C Process for the enzymatic cleavage of recombinant proteins using iga proteases
12/07/1999CA2015515C Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
12/07/1999CA2012686C Treatment and compounds
12/07/1999CA2007740C Substituted quinolinecarboxylic acids
12/02/1999WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999WO1999061056A2 Methods and products for inducing mucosal immunity
12/02/1999WO1999061054A1 Nicotine immunogen
12/02/1999WO1999061053A1 Combination meningitidis b/c vaccines
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061051A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061026A1 Efavirenz compressed tablet formulation
12/02/1999WO1999061025A1 Microemulsion preconcentrates containing a piperidine substance p antagonist
12/02/1999WO1999061020A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
12/02/1999WO1999061019A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
12/02/1999WO1999061013A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
12/02/1999WO1999061001A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
12/02/1999WO1999060997A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
12/02/1999WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999WO1999044636A3 Il-12 enhancement of immune responses to t-independent antigens
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2333159A1 Method
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332999A1 Compounds having ige affecting properties
12/02/1999CA2332989A1 Benzimidazole derivatives as modulators of ige
12/02/1999CA2332985A1 Benzimidazole analogs as down-regulators of ige
12/02/1999CA2332963A1 Combination meningitidis b/c vaccines
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328894A1 Methods and products for inducing mucosal immunity
1 ... 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 ... 1172